Insertion/deletion polymorphism of angiotensin-1 converting enzyme is associated with metabolic syndrome in Hungarian adults

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 12, Issue 4, 2011, Pages 531-538

  Fiatal, Szilvia ^a   Szigethy, Endre ^a   Széles, György ^b   Tóth, Réka ^b   Ádány, Róza ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

ACE I D polymorphism; Caucasian; genetics; Hungarian; metabolic syndrome

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; HUNGARY; HYPERTENSION; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNGARY; INDEL MUTATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 83455195572     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320310394231     Document Type: Article

References (42)

1. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 ; 37: 1595-1607 (Pubitemid 19004941)
2. Jama. 2001 ; 285: 2486-2497
3. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet. 2005 ; 366: 1059-1062 (Pubitemid 41338752)
4. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care. 2004 ; 27: 2444-2449 (Pubitemid 39281399)
5. Ardern CI, Katzmarzyk PT, Janssen I, Ross R. Discrimination of health risk by combined body mass index and waist circumference. Obes Res. 2003 ; 11: 135-142 (Pubitemid 41137549)
6. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Jama. 2002 ; 287: 356-359 (Pubitemid 34251969)
7. Szigethy E, Voko Z, Jermendy G, et al. The epidemiology of metabolic syndrome in the Hungarian adult population. Diab Vasc Dis Res. 2007 ; 4: S94
8. Eriksson J, Taimela S, Koivisto VA. Exercise and the metabolic syndrome. Diabetologia. 1997 ; 40: 125-135 (Pubitemid 27060283)
9. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003 ; 26: 575-581 (Pubitemid 36929310)
10. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005 ; 28: 1769-1778 (Pubitemid 40923091)
11. Roche HM, Phillips C, Gibney MJ. The metabolic syndrome: the crossroads of diet and genetics. Proc Nutr Soc. 2005 ; 64: 371-377 (Pubitemid 41160767)
12. Langefeld CD, Wagenknecht LE, Rotter JI, et al. Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study. Diabetes. 2004 ; 53: 1170-1174 (Pubitemid 38436635)
13. Kissebah AH, Sonnenberg GE, Myklebust J, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA. 2000 ; 97: 14478-14483 (Pubitemid 32016601)
14. Kékes E, Czuriga I. The metabolic syndrome-clinical appearance, diagnosis, pathomechanism. Lege Artis Med. 2004 ; 14: 7-16 (Pubitemid 38200483)
15. Hamid YH, Rose CS, Urhammer SA, et al. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia. 2005 ; 48: 251-260 (Pubitemid 40543296)
16. Steinle NI, Kazlauskaite R, Imumorin IG, et al. Variation in the lamin A/C gene: associations with metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004 ; 24: 1708-1713 (Pubitemid 39180899)
17. Frederiksen L, Brodbaek K, Fenger M, et al. Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab. 2002 ; 87: 3989-3992 (Pubitemid 34879559)
18. Lee YJ, Tsai JC. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care. 2002 ; 25: 1002-1008 (Pubitemid 41110485)
19. Thomas GN, Tomlinson B, Chan JC, Sanderson JE, Cockram CS, Critchley JA. Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of tne ACE insertion/deletion polymorphism with type 2 diabetes. Diabetes Care. 2001 ; 24: 356-361 (Pubitemid 32119138)
20. McCarthy JJ, Meyer J, Moliterno DJ, Newby LK, Rogers WJ, Topol EJ. Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. Hum Genet. 2003 ; 114: 87-98 (Pubitemid 38165539)
21. Dallongeville J, Helbecque N, Cottel D, Amouyel P, Meirhaeghe A. The Gly16->Arg16 and Gln27->Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men. J Clin Endocrinol Metab. 2003 ; 88: 4862-4866
22. Matsusaka T, Hymes J, Ichikawa I. Angiotensin in progressive renal diseases: theory and practice. J Am Soc Nephrol. 1996 ; 7: 2025-2043 (Pubitemid 27468232)
23. Nicholls MG, Richards AM, Agarwal M. The importance of the renin-angiotensin system in cardiovascular disease. J Hum Hypertens. 1998 ; 12: 295-299 (Pubitemid 28274359)
24. Ferrannini E, Seghieri G, Muscelli E. Insulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition. J Cardiovasc Pharmacol. 1994 ; 24: S61-9
25. Nikzamir A, Nakhjavani M, Golmohamadi T, Dibai L. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with metabolic syndrome in iranians with type 2 diabetes mellitus. Arch Iran Med. 2008 ; 11: 3-9 (Pubitemid 351233542)
26. Nagi DK, Foy CA, Mohamed-Ali V, Yudkin JS, Grant PJ, Knowler WC. Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians. Metabolism. 1998 ; 47: 622-626 (Pubitemid 28213126)
27. Costa LA, Canani LH, Maia AL, Gross JL. The ACE insertion/deletion polymorphism is not associated with the metabolic syndrome (WHO Definition) in Brazilian type 2 diabetic patients. Diabetes Care. 2002 ; 25: 2365-2366
28. Alvarez-Aguilar C, Enriquez-Ramirez ML, Figueroa-Nunez B, et al. Association between angiotensin-1 converting enzyme gene polymorphism and the metabolic syndrome in a Mexican population. Exp Mol Med. 2007 ; 39: 327-334 (Pubitemid 47037623)
29. Milionis HJ, Kostapanos MS, Vakalis K, et al. Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome. J Renin Angiotensin Aldosterone Syst. 2007 ; 8: 181-189 (Pubitemid 351166265)
30. Sivakova D, Lajdova A, Basistova Z, Cvicelova M, Blazicek P. ACE insertion/deletion polymorphism and its relationships to the components of metabolic syndrome in elderly Slovaks. Anthropol Anz. 2009 ; 67: 1-11
31. Szeles G, Voko Z, Jenei T, et al. Establishment and preliminary evaluation of the General Practitioners' Morbidity Sentinel Stations Program in Hungary. Prevalence of hypertension, diabetes mellitus and liver cirrhosis. Orvosi Hetilap. 2003 ; 144: 1521-1529
32. Csaszar A, Kekes E, Abel T, Papp R, Kiss I, Balogh S. Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population. Blood Press. 2006 ; 15: 101-106 (Pubitemid 43878916)
33. Malin R, Wirta V, Hiltunen TP, Lehtimaki T. Rapid detection of angiotensinogen M/T235 polymorphism by fluorescence probe melting curves. Clin Chem. 2000 ; 46: 880-881 (Pubitemid 30397462)
34. Somogyvari F, Szolnoki Z, Marki-Zay J, Fodor L. Real-time PCR assay with fluorescent hybridization probes for exact and rapid genotyping of the angiotensin-converting enzyme gene insertion/deletion polymorphism. Clin Chem. 2001 ; 47: 1728-1729 (Pubitemid 32781599)
35. Staessen JA, Ginocchio G, Wang JG, et al. Genetic variability in the renin-angiotensin system: prevalence of alleles and genotypes. J Cardiovasc Risk. 1997 ; 4: 401-422 (Pubitemid 28078684)
36. Pollex RL, Hanley AJ, Zinman B, Harris SB, Khan HM, Hegele RA. Metabolic syndrome in aboriginal Canadians: prevalence and genetic associations. Atherosclerosis. 2006 ; 184: 121-129 (Pubitemid 41721078)
37. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol. 2000 ; 20: 484-492 (Pubitemid 30086107)
38. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol. 2003 ; 23: 1269-1275 (Pubitemid 36871283)
39. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens. 1999 ; 17: 555-560 (Pubitemid 29308566)
40. Pepine CJ, Cooper-Dehoff RM. Cardiovascular therapies and risk for development of diabetes. J Am Coll Cardiol. 2004 ; 44: 509-512 (Pubitemid 39078171)
41. Takakura Y, Yoshida T, Yoshioka K, et al. Angiotensinogen gene polymorphism (Met235Thr) influences visceral obesity and insulin resistance in obese Japanese women. Metabolism. 2006 ; 55: 819-824
42. Guo X, Cheng S, Taylor KD, et al. Hypertension genes are genetic markers for insulin sensitivity and resistance. Hypertension. 2005 ; 45: 799-803 (Pubitemid 40418384)